表紙:抗凝固拮抗薬の世界市場:製品タイプ(プロトロンビン複合体濃縮物、フィトナジオン、アンデキサネットアルファ、イダルシズマブ、プロタミン)別、流通チャネル別の市場規模、シェアおよび動向分析、セグメント別予測(2020年~2027年)
市場調査レポート
商品コード
989738

抗凝固拮抗薬の世界市場:製品タイプ(プロトロンビン複合体濃縮物、フィトナジオン、アンデキサネットアルファ、イダルシズマブ、プロタミン)別、流通チャネル別の市場規模、シェアおよび動向分析、セグメント別予測(2020年~2027年)

Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine), By Distribution Channel, And Segment Forecasts, 2020 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 110 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.57円
抗凝固拮抗薬の世界市場:製品タイプ(プロトロンビン複合体濃縮物、フィトナジオン、アンデキサネットアルファ、イダルシズマブ、プロタミン)別、流通チャネル別の市場規模、シェアおよび動向分析、セグメント別予測(2020年~2027年)
出版日: 2021年02月12日
発行: Grand View Research, Inc.
ページ情報: 英文 110 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗凝固拮抗薬の市場規模は、2020年から2027年にかけて14.3%のCAGRで拡大し、2027年までに18億1,000万米ドルに達すると予想されています。出血性疾患の増加、新薬の導入、および抗凝固療法を必要とする症例数の増加などが、予測期間中に市場成長を促進すると予想される要因です。

2015年10月、 Boehringer Ingelheim Pharmaceuticals のPraxbind(イダルシズマブ)は、緊急手術中または制御不能または生命を脅かす出血中にPradaxa(ダビガトラン)で治療された患者に適応される抗凝固拮抗薬として承認されました。したがって、これらの抗凝固拮抗薬の入手可能性により、医師と患者はそのような治療オプションをより自信を持って検討することができ、抗凝固拮抗薬の需要が高まります。

当レポートでは、世界の抗凝固拮抗薬市場について調査分析し、市場および業界の見通し、セグメント別・地域別の見通しのほか、競合情勢について、体系的な情報を提供しています。

目次

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 抗凝固拮抗薬市場の変数、動向および範囲

  • 市場系統の見通し
  • 浸透と成長の見通しのマッピング
  • 市場力学
  • 抗凝固拮抗薬市場分析ツール

第4章 抗凝固拮抗薬市場-競合分析

  • 主要な市場参加者別最新動向と影響分析
  • ベンダー情勢
    • 主要な流通業者とチャネルパートナーのリスト
  • 公開企業
    • 企業の市況分析
    • 競合のダッシュボード分析
  • 非公開企業
    • 主要な新興企業のリスト
    • 地域ネットワークマップ
    • 企業の市況分析

第5章 抗凝固拮抗薬市場:製品タイプ別市場の推計・動向分析

  • 定義と範囲
  • 製品タイプ別市場シェア分析、2019年および2027年
  • セグメントダッシュボード
  • 世界の抗凝固拮抗薬市場、製品タイプ、2016年~2027年
  • 市場規模と予測および動向分析、2016年~2027年
    • プロトロンビン複合体濃縮物
    • フィトナジオン
    • アンデキサネットアルファ
    • イダルシズマブ
    • プロタミン
    • その他

第6章 抗凝固拮抗薬市場:流通チャネル別市場の推計・動向分析

  • 定義と範囲
  • 流通チャネル別市場シェア分析、2019年および2027年
  • セグメントダッシュボード
  • 世界の抗凝固拮抗薬市場、流通チャネル別、2016年~2027年
  • 市場規模と予測および動向分析、2016年~2027年
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第7章 抗凝固拮抗薬市場:地域別市場の推計・動向分析

  • 地域市場のスナップショット
  • 地域別市場シェアと主要企業、2019年
    • 北米
    • 欧州
    • ラテンアメリカ
    • アジア太平洋地域
    • 中東・アフリカ
  • 国別の市場シェア分析、2019年
    • 北米
    • 欧州
    • ラテンアメリカ
    • アジア太平洋地域
    • 中東・アフリカ
  • 要因別のSWOT分析(政治的および法的、経済的および技術的)
    • 北米
    • 欧州
    • ラテンアメリカ
    • アジア太平洋地域
    • 中東・アフリカ
  • 市場規模と予測、および動向分析、2019年~2027年
    • 北米
    • 欧州
    • ラテンアメリカ
    • アジア太平洋地域
    • 中東・アフリカ

第8章 企業プロファイル

  • 企業プロファイル
図表

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America anticoagulant reversal drugs market, by country, 2016 - 2027 (USD Million)
  • Table 4 North America anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 5 North America anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 6 U.S. anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 7 U.S. anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 8 Canada anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 9 Canada anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 10 Europe anticoagulant reversal drugs market, by country, 2016 - 2027 (USD Million)
  • Table 11 Europe anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 12 Europe anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 13 Germany anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 14 Germany anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 15 U.K. anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 16 U.K. anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 17 France anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 18 France anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 19 Italy anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 20 Italy anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 21 Spain anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 22 Spain anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 23 Russia anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 24 Russia anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 25 Asia Pacific anticoagulant reversal drugs market, by country, 2016 - 2027 (USD Million)
  • Table 26 Asia Pacific anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 27 Asia Pacific anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 28 Japan anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 29 Japan anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 30 China anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 31 China anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 32 India anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 33 India anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 34 Australia anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 35 Australia anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 36 South Korea anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 37 South Korea anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 38 Singapore anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 39 Singapore anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 40 Latin America anticoagulant reversal drugs market, by country, 2016 - 2027 (USD Million)
  • Table 41 Latin America anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 42 Latin America anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 43 Brazil anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 44 Brazil anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 45 Mexico anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 46 Mexico anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 47 Argentina anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 48 Argentina anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 49 MEA anticoagulant reversal drugs market, by country, 2016 - 2027 (USD Million)
  • Table 50 MEA anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 51 MEA anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 52 South Africa anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 53 South Africa anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 54 Saudi Arabia anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 55 Saudi Arabia anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 56 UAE anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 57 UAE anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Anticoagulant reversal drugs market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Anticoagulant reversal drugs market snapshot (2019)
  • Fig. 7 Anticoagulant reversal drugs market: Segment snapshot (2019)
  • Fig. 8 Competitive Insights (2019)
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Anticoagulant reversal drugs market driver impact
  • Fig. 13 Anticoagulant reversal drugs market restraint impact
  • Fig. 14 Anticoagulant reversal drugs industry challenges
  • Fig. 15 Porter's Five Forces Analysis
  • Fig. 16 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 17 Strategic alliance analysis
  • Fig. 18 Recent developments & impact analysis, by key market participants
  • Fig. 19 Key company market share analysis, 2019
  • Fig. 20 Company market position analysis
  • Fig. 21 Definition and scope, by product type
  • Fig. 22 Product Type market share analysis, 2019 & 2027
  • Fig. 23 Segment dashboard
  • Fig. 24 Global anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Fig. 25 Prothrombin complex concentrates market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 26 Phytonadione market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 27 Andexanet alfa market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 28 Idarucizumab market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 29 Protamine market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 30 Others market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 31 Definition and scope, by distribution channel
  • Fig. 32 Distribution channel market share analysis, 2019 & 2027
  • Fig. 33 Segment dashboard
  • Fig. 34 Global anticoagulant reversal drugs market, by distribution channel, 2016-2027 (USD Million)
  • Fig. 35 Hospital pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 36 Retail pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 37 Online pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 38 Anticoagulant reversal drugs market: Snapshot, 2019
  • Fig. 39 North America anticoagulant reversal drugs market share and leading players, 2019
  • Fig. 40 Europe anticoagulant reversal drugs market share and leading players, 2019
  • Fig. 41 Asia Pacific anticoagulant reversal drugs market share and leading players, 2019
  • Fig. 42 Latin America anticoagulant reversal drugs market share and leading players, 2019
  • Fig. 43 Middle East and Africa anticoagulant reversal drugs market share and leading players, 2019
  • Fig. 44 North America market share analysis by country, 2019
  • Fig. 45 Europe market share analysis by country, 2019
  • Fig. 46 Asia Pacific market share analysis by country, 2019
  • Fig. 47 Latin America market share analysis by country, 2019
  • Fig. 48 Middle East and Africa market share analysis by country, 2019
  • Fig. 49 North America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 50 Europe SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 51 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 52 Latin America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 53 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 54 North America market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 55 U.S. market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 56 Canada market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 57 Europe market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 58 U.K. market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 59 Germany market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 60 Spain market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 61 France market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 62 Italy market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 63 Russia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 64 Asia Pacific market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 65 China market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 66 Japan market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 67 India market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 68 Australia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 69 South Korea market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 70 Singapore market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 71 Latin America market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 72 Brazil market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 73 Mexico market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 74 Argentina market size, & forecasts and trend analysis, 2016 to 2027 (USD Million))
  • Fig. 75 Middle East and Africa market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 76 South Africa market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 77 Saudi Arabia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 78 UAE market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
目次
Product Code: GVR-4-68039-293-5

Anticoagulant Reversal Drugs Market Growth & Trends

The global anticoagulant reversal drugs market size is expected to reach USD 1.81 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.3% from 2020 to 2027. The rising number of bleeding disorders, the introduction of new drugs, and the growing number of cases requiring anticoagulant therapies are some of the factors anticipated to foster market growth during the forecast period.

In October 2015, Praxbind (idarucizumab) by Boehringer Ingelheim Pharmaceuticals was approved as an anticoagulant reversal drug indicated for patients treated with Pradaxa (dabigatran) during emergency surgery or uncontrolled or life-threatening bleeding. Hence, the availability of these anticoagulation reversal drugs allows doctors and patients to consider such treatment options with greater confidence, therefore boosting the demand for anticoagulant reversal drugs.

Bleeding disorders like hemophilia can be acquired or inherited. However, other bleeding disorders can occur from conditions, such as HIV, anemia, leukemia, cirrhosis of the liver, and vitamin K deficiency. According to the National Heart, Lung, and Blood Institute, more than 3 million people in the U.S. are affected with anemia, which is the most common blood disorder. The Leukemia & Lymphoma Society (LLS) stated that in the year 2020, the number of people expected to be diagnosed with leukemia is around 60,530. A rise in bleeding disorders is increasing the demand for anticoagulants, thus fueling the market growth.

However, the high cost of these reversal therapies is anticipated to restrain the market growth. As per the American College of Cardiology, 4-F PCC (Kcentra) helps in treating bleeding cases caused by rivaroxaban and apixaban and it is dosed at 50 units/kg. Its average wholesale price is USD 2.90 per unit, therefore treating a patient whose weight is 100 kg would cost around USD 14,500.

Anticoagulant Reversal Drugs Market Report Highlights

  • By product type, idarucizumab held the largest share in 2019 as it is currently approved in many countries, including the U.S., Europe, Canada, and Australia. Andexanet alfa is expected to witness lucrative growth over the forecast period owing to its approval and launch in key markets
  • Based on distribution channel, in 2019, the hospital pharmacy segment accounted for the largest share due to increased preference for hospital settings to treat the emergency cases during uncontrolled bleeding
  • North America dominated the market in 2019 due to the high affordability and easy availability of such costly drugs in the U.S.
  • The Asia Pacific market is expected to witness the fastest growth over the forecast period owing to the increasing awareness about bleeding disorders in emerging economies, such as India and China
  • The annual cost of treating 10 to 20 patients with idarucizumab ranges from USD 34,825 to USD 69,650, respectively with a single 5 g dose, thus hindering its demand in under-developed countries

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Market definition
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information analysis
    • 1.4.1 Data analysis models
  • 1.5 Market formulation & data visualization
  • 1.6 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Anticoagulant Reversal Drugs Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Approval and launch of novel drugs
      • 3.3.1.2 Increasing prevalence of bleeding disorders
      • 3.3.1.3 Rise in incidence of indications for anticoagulant therapy
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 High cost of reversal therapies
    • 3.3.3 Industry challenges
  • 3.4 Anticoagulant Reversal Drugs Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
      • 3.4.1.1 Supplier Power
      • 3.4.1.2 Buyer Power
      • 3.4.1.3 Substitution Threat
      • 3.4.1.4 Threat from new entrants
      • 3.4.1.5 Competitive Rivalry
    • 3.4.2 PESTEL Analysis
      • 3.4.2.1 Political Landscape
      • 3.4.2.2 Environmental Landscape
      • 3.4.2.3 Social landscape
      • 3.4.2.4 Application landscape
      • 3.4.2.5 Legal Landscape

Chapter 4 Anticoagulant Reversal Drugs Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Vendor Landscape
    • 4.2.1 List of key distributors and channel partners
    • 4.2.2 Key company market share analysis, 2019
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
    • 4.3.2 Competitive dashboard analysis
  • 4.4 Private Companies
    • 4.4.1 List of key emerging companies
    • 4.4.2 Regional network map
    • 4.4.3 Company market position analysis

Chapter 5 Anticoagulant Reversal Drugs Market: Product Type Estimates And Trend Analysis

  • 5.1 Definition & Scope
  • 5.2 Product Type Market Share Analysis, 2019 & 2027
  • 5.3 Segment Dashboard
  • 5.4 Global Anticoagulant Reversal Drugs Market, by Product Type, 2016 to 2027
  • 5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 5.5.1 Prothrombin Complex Concentrates
      • 5.5.1.1 Prothrombin Complex Concentrates Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.2 Phytonadione
      • 5.5.2.1 Phytonadione Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.3 Andexanet Alfa
      • 5.5.3.1 Andexanet Alfa Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.4 Idarucizumab
      • 5.5.4.1 Idarucizumab Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.5 Protamine
      • 5.5.5.1 Protamine Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.6 Others
      • 5.5.6.1 Others Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 6 Anticoagulant Reversal Drugs Market: Distribution Channel Estimates And Trend Analysis

  • 6.1 Definition & Scope
  • 6.2 Distribution Channel Market Share Analysis, 2019 & 2027
  • 6.3 Segment Dashboard
  • 6.4 Global Anticoagulant Reversal Drugs Market, by Distribution Channel, 2016 to 2027
  • 6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 6.5.1 Hospital Pharmacy
      • 6.5.1.1 Hospital Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 6.5.2 Retail Pharmacy
      • 6.5.2.1 Retail Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 6.5.3 Online Pharmacy
      • 6.5.3.1 Online Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 7 Anticoagulant Reversal Drugs Market: Regional Estimates & Trend Analysis

  • 7.1 Regional Market Snapshot
  • 7.2 Regional Market Share and Leading Players, 2019
    • 7.2.1 North America
    • 7.2.2 Europe
    • 7.2.3 Latin America
    • 7.2.4 Asia Pacific
    • 7.2.5 Middle East & Africa
  • 7.3 Market Share Analysis by Country, 2019
    • 7.3.1 North America
      • 7.3.1.1 U.S.
      • 7.3.1.2 Canada
    • 7.3.2 Europe
      • 7.3.2.1 U.K.
      • 7.3.2.2 Germany
      • 7.3.2.3 Spain
      • 7.3.2.4 France
      • 7.3.2.5 Italy
      • 7.3.2.6 Russia
    • 7.3.3 Latin America
      • 7.3.3.1 Brazil
      • 7.3.3.2 Mexico
      • 7.3.3.3 Argentina
    • 7.3.4 Asia Pacific
      • 7.3.4.1 Japan
      • 7.3.4.2 China
      • 7.3.4.3 India
      • 7.3.4.4 South Korea
      • 7.3.4.5 Singapore
      • 7.3.4.6 Australia
    • 7.3.5 Middle East & Africa
      • 7.3.5.1 South Africa
      • 7.3.5.2 Saudi Arabia
      • 7.3.5.3 UAE
  • 7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.4.1 North America
    • 7.4.2 Europe
    • 7.4.3 Latin America
    • 7.4.4 Asia Pacific
    • 7.4.5 Middle East & Africa
  • 7.5 Market Size & Forecasts, and Trend Analysis, 2019 to 2027
    • 7.5.1 North America
      • 7.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.1.2 U.S.
      • 7.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.1.3 Canada
      • 7.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.2 Europe
      • 7.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.2.2 U.K.
      • 7.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.3 Germany
      • 7.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.4 Spain
      • 7.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.5 France
      • 7.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.6 Italy
      • 7.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.7 Russia
      • 7.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.3 Latin America
      • 7.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.3.2 Brazil
      • 7.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.3.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.3.3 Mexico
      • 7.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.3.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.3.4 Argentina
      • 7.5.3.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.3.4.2 Argentina Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.4 Asia Pacific
      • 7.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.4.2 Japan
      • 7.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.2.2 Japan Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.3 China
      • 7.5.4.3.1 China Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.3.2 China Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.4 India
      • 7.5.4.4.1 India Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.4.2 India Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.5 South Korea
      • 7.5.4.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.5.2 South Korea Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.6 Singapore
      • 7.5.4.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.6.2 Singapore Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.7 Australia
      • 7.5.4.7.1 Australia Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.7.2 Australia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.5 Middle East & Africa
      • 7.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.5.2 South Africa
      • 7.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.5.3 Saudi Arabia
      • 7.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.5.4 UAE
      • 7.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)

Chapter 8 COMPANY PROFILE

  • 8.1 Company Profiles
    • 8.1.1 Portola Pharmaceuticals
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product benchmarking
      • 8.1.1.4 Strategic initiatives
    • 8.1.2 Boehringer Ingelheim
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product benchmarking
      • 8.1.2.4 Strategic initiatives
    • 8.1.3 CSL Behring
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product benchmarking
      • 8.1.3.4 Strategic initiatives
    • 8.1.4 Bausch Health Companies Inc.
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product benchmarking
      • 8.1.4.4 Strategic initiatives
    • 8.1.5 Octapharma AG
      • 8.1.5.1 Company overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product benchmarking
      • 8.1.5.4 Strategic initiatives
    • 8.1.6 Dr. Reddy's Laboratories
      • 8.1.6.1 Company overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Product benchmarking
      • 8.1.6.4 Strategic initiatives
    • 8.1.7 AMAG Pharmaceuticals, Inc.
      • 8.1.7.1 Company overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product benchmarking
      • 8.1.7.4 Strategic initiatives
    • 8.1.8 Pfizer, Inc.
      • 8.1.8.1 Company overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product benchmarking
      • 8.1.8.4 Strategic initiatives
    • 8.1.9 SGPharma Pvt. Ltd.
      • 8.1.9.1 Company overview
      • 8.1.9.2 Financial Performance
      • 8.1.9.3 Product benchmarking
      • 8.1.9.4 Strategic initiatives
    • 8.1.10 Alps Pharmaceutical Ind. Co., Ltd.
      • 8.1.10.1 Company overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Product benchmarking
      • 8.1.10.4 Strategic initiatives
    • 8.1.11 Fresenius Kabi AG
      • 8.1.11.1 Company overview
      • 8.1.11.2 Financial Performance
      • 8.1.11.3 Product benchmarking
      • 8.1.11.4 Strategic initiatives